share_log

Tharimmune | DEFA14A: Others

SEC announcement ·  Mar 22 23:17
Summary by Futu AI
Tharimmune, a company listed in the United States, has filed a definitive additional materials proxy statement with the Securities and Exchange Commission (SEC). This filing, known as Schedule 14A, is a requirement under Section 14(a) of the Securities Exchange Act of 1934 and is used to provide shareholders with information necessary to vote on important company matters. Tharimmune has confirmed that no filing fee was required for this submission. The materials filed are definitive, meaning they are the final version provided to shareholders for their consideration.
Tharimmune, a company listed in the United States, has filed a definitive additional materials proxy statement with the Securities and Exchange Commission (SEC). This filing, known as Schedule 14A, is a requirement under Section 14(a) of the Securities Exchange Act of 1934 and is used to provide shareholders with information necessary to vote on important company matters. Tharimmune has confirmed that no filing fee was required for this submission. The materials filed are definitive, meaning they are the final version provided to shareholders for their consideration.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.